Rhus succedanea L., a tree belonging to the Anacardiaceae family is also known as Kuntze.
Traditional systems of medicine have used Rhus succedanea L. to treat a variety of ailments
like infections, dysentery, nose and gum bleeding, cough, tuberculosis, fever, and asthma.
Several phytoconstituents such as robustaflavone, volkensiflavone, agathisflavone, succedanea
flavanone, and rhusflavone have been isolated from this plant species responsible for several
pharmacological actions. The anti-inflammatory, anti-diabetic, antioxidant, antibacterial,
anticancer, antileukemic, and antiviral properties of Rhus succedanea L. have been revealed
using various parts of the plant, proving the validity of its traditional use. After an extensive
literature survey through the relevant publications in the databases Web of Science, Scopus,
ScienceDirect, and PubMed, it was found that the literature that is currently accessible on Rhus
succedanea L. indicates a lack of compiled information on pharmacological research
conducted. This review aims to assess, compile, and address the traditional and folk medicinal
uses, phytochemistry, and pharmacology including various preclinical studies of Rhus
succedanea L. to date.
Keywords: Bioactivities; Rhus succedanea; Toxicodendron succedaneum;
Phytochemistry; Toxicity
Publication date: 01/04/2025
https://ijbpas.com/pdf/2025/April/MS_IJBPAS_2025_8909.pdf
Download PDF
https://doi.org/10.31032/IJBPAS/2025/14.4.8909
